Eisai Wins Patent Lawsuit For Proton Pump Inhibitor AcipHex
This article was originally published in PharmAsia News
Executive Summary
TOKYO - In a decision that would bolster its underlying profit-making structure and spur its intellectual property protection policy, Eisai July 22 said it won a patent lawsuit for its proton pump inhibitor AcipHex, one of its two leading global pharmaceutical products, in the U.S